Icon Legend

This session is not in your agenda.

This session is in your agenda. Click to remove it

Browse by Author

Home
Browse by Author

Browse by Author

Type here to filter the list

G
Gómez-Apo, E

Mexico General Hospital

P-104 - (Poster #104) Histological Findings After Electromagnetic Field Stimulation in a Sciatic Nerve Constriction Model in Rats for Neuropathic Pain
Location: Exhibit Hall (Level 4)

E Gómez-Apo

Favorite

P-105 - (Poster #105) Motor Changes in a Sciatic Nerve Constriction Model in Rats Using Electromagnetic Fields in a Long-Term Follow-Up
Location: Exhibit Hall (Level 4)

E Gómez-Apo

Favorite

Garofoli, Mark

West Virginia University & West Virginia University Medicine

PDM-02 - (Sponsored Lunch Presentation) Dual NMR Agonists to overcome the Current Shortfalls in the Management of Severe Acute Pain: Break the Mold in Pain Biology
Location: Brera Ballroom (Level 3)

Mark Garofoli

Favorite

PHM-02 - Pain for the (Geriatric) Ages: Overcoming the Challenges of Treating Longevity
Location: Mont Royal (Level 4)

Mark Garofoli

Favorited

PHM-05 - (2-hour) Entering the Matrix: Mechanisms & Medications
Location: Nolita (Level 4)

Mark Garofoli

Favorite

Gayer, Gregory

Touro University College of Osteopathic Medicine

P-110 - (Poster #110) What are the mechanisms and clinical implications of gabapentin-induced myoclonus?
Location: Exhibit Hall (Level 4)

Gregory Gayer

Favorite

Geddis, Connor

Haleon

P-080 - (Poster #80) A Global Pain Index Assessment of the Emotional and Psychological Impact of Pain and Its Contribution to Isolation in the Elderly
Location: Exhibit Hall (Level 4)

Connor Geddis

Favorite

P-081 - (Poster #81) Clinical Evidence with the Combination of Ibuprofen and Diphenhydramine for the Management of Pain and Sleeplessness
Location: Exhibit Hall (Level 4)

Connor Geddis

Favorited

P-085 - (Poster #85) A Study of the Fixed Dose Combination of Ibuprofen and Acetaminophen for the Treatment of Moderate and Severe Dental Pain
Location: Exhibit Hall (Level 4)

Connor Geddis

Favorited

Georgescu, Alexandru

Haleon

P-083 - (Poster #83) A prospective, real-world evidence study evaluating the effect of topical diclofenac (Voltaren gel) on functional mobility and quality of life in adults with osteoarthritis of the knee
Location: Exhibit Hall (Level 4)

Alexandru Georgescu

Favorite

Gevariya, Harsukh

Triangle Molecular Toxicology Lab

SIS-04 - A Lab's Perspective: The Future of Therapeutic Drug Testing
Location: Castellana 1 (Level 3)

Harsukh Gevariya

Favorited

Glants, Erica

Nova Southeastern College of Osteopathic Medicine

P-095 - (Poster #95) Integrating Medical Marijuana into Chronic Pain Management: Efficacy, Barriers, and Functional Outcomes
Location: Exhibit Hall (Level 4)

Erica Glants

Favorite

P-096 - (Poster #96) Investigating the Potential Role of MK-677 in Chronic Pain Modulation
Location: Exhibit Hall (Level 4)

Erica Glants

Favorite

Gleason, Julia

Kenvue Brands LLC

P-030 - (Poster #30) Readability of Patient Pain Management Instructions for Toothache or After Dental Extraction and Concordance with American Dental Association Guidelines
Location: Exhibit Hall (Level 4)

Julia Gleason

Favorite

P-031 - (Poster #31) Readability of Patient Pain Medication Management Instructions for Regimens Which Alternate Acetaminophen and Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Location: Exhibit Hall (Level 4)

Julia Gleason

Favorite

Glick, David

HealthQ2

INTV-05 - X-Ray Vision: Transforming Perspectives of Imaging Studies to Treat Pain
Location: Nolita (Level 4)

David Glick

Favorite

PHM-05 - (2-hour) Entering the Matrix: Mechanisms & Medications
Location: Nolita (Level 4)

David Glick

Favorite

Gofman, Joseph

Total Neuro Care

P-095 - (Poster #95) Integrating Medical Marijuana into Chronic Pain Management: Efficacy, Barriers, and Functional Outcomes
Location: Exhibit Hall (Level 4)

Joseph Gofman

Favorite

Gold, Morris

IQVIA

P-084 - (Poster #84) Comparative Systemic Bioavailability of Topical Diclofenac Sodium Gel 1% vs Topical Diclofenac Diethylamine Gel 1.16%
Location: Exhibit Hall (Level 4)

Morris Gold

Favorite

Gong, Xuechun

Shanghai Simrbio Tech.

P-071 - (Poster #71) Quantitative Sensory Testing of SR419, a First-in-Class Oral α5-GABAA Receptor Negative Allosteric Modulator, in Neuropathic Pain Patients
Location: Exhibit Hall (Level 4)

Xuechun Gong

Favorite

Gonzalez, Christian

American Academy of Pain Management

EOL-04 - (Expert Opinion Live) The Future of Risk Mitigation: New Technologies and Platforms for Prescribing in a Digital Age
Location: Exhibit Hall (Level 4)

Christian Gonzalez

Favorite

Gopinathan, Suma

Lexicon Pharmaceuticals

P-053 - (Poster #53) Listening to Patients with Diabetic Peripheral Neuropathic Pain: Insights from a Patient Survey to Inform Advanced Clinical Development of Pilavapadin
Location: Exhibit Hall (Level 4)

Suma Gopinathan

Favorite

Goree, Johnathan

University of Arkansas for Medical Science

PNL-02 - (Ask the Panel) In the k"NOW": The Current Business of Pain
Location: Nolita (Level 4)

Johnathan Goree

Favorite

PNL-03 - (Ask the Panel) Un-Blocking Potential: Overcoming Barriers in Pain Management
Location: Mont Royal (Level 4)

Johnathan Goree

Favorited

PRC-01 - PAINWeek PreCon - Rounds of Resilience: Optimizing Pain Management Through Interactive Difficult Case Navigation
Location: Nolita (Level 4)

Johnathan Goree

Favorite

Goro, Larsa

UC San Diego, Skaggs School of Pharmacy & Pharm. Sci.

P-002 - (Poster #2) Single-center, retrospective study to estimate opioid-induced respiratory depression and/or oversedation risk in hospitalized patients with cancer receiving palliative care
Location: Exhibit Hall (Level 4)

Larsa Goro

Favorite

Gottlieb, Ira

Chesapeake Research Group, LLC

P-039 - (Poster #39) Efficacy and safety of MR-107A-02 (novel fast-acting meloxicam formulation) for the treatment of acute moderate-to-severe pain following bunionectomy
Location: Exhibit Hall (Level 4)

Ira Gottlieb

Favorite

P-040 - (Poster #40) Opioid sparing effect of MR-107A-02 (novel fast-acting meloxicam formulation) for the treatment of acute moderate-to-severe pain following bunionectomy and herniorrhaphy
Location: Exhibit Hall (Level 4)

Ira Gottlieb

Favorite

Gould, Errol

Tonix Pharmaceuticals, Inc.

P-036 - (Poster #36) Sublingual cyclobenzaprine (TNX-102 SL) for fibromyalgia: efficacy and safety in two randomized placebo-controlled trials
Location: Exhibit Hall (Level 4)

Errol Gould

Favorite

P-037 - (Poster #37) TNX-102 SL, cyclobenzaprine HCl sublingual tablets, demonstrates pain reduction and favorable tolerability in patients with fibromyalgia
Location: Exhibit Hall (Level 4)

Errol Gould

Favorite

P-045 - (Poster #45) Steady-state pharmacokinetic properties of a sublingual formulation of cyclobenzaprine (CBP) HCl (TNX-102 SL): comparison to simulations of oral immediate-release CBP
Location: Exhibit Hall (Level 4)

Errol Gould

Favorite

Grbic, Dimitrije

ZRx Outcomes Research Inc.

P-010 - (Poster #10) Treatment Characteristics and Safety of Belbuca, Buprenorphine Patch, and Oral Schedule II Opioid Treatments among Chronic Low Back Pain Patients without Positive History of Opioid-Use Disorder: A Retrospective US Commercial Claims Analysis
Location: Exhibit Hall (Level 4)

Dimitrije Grbic

Favorite

P-011 - (Poster #11) Economic Burden of Chronic Low Back Pain Patients Transitioned from Oral Schedule II Short-Acting Opioids to Belbuca or Oral Schedule II Long-Acting Opioids: A Retrospective US Commercial Claims Analysis
Location: Exhibit Hall (Level 4)

Dimitrije Grbic

Favorite

P-015 - (Poster #15) Treatment Characteristics of Chronic Low Back Pain Patients Transitioned from Oral Schedule II Short-Acting Opioids to Belbuca or Oral Schedule II Long-Acting Opioids: A Retrospective US Commercial Claims Analysis
Location: Exhibit Hall (Level 4)

Dimitrije Grbic

Favorite

P-016 - (Poster #16) A Retrospective US Commercial Claims Analysis Comparing the Safety Profile of Belbuca and Oral Schedule II Long-Acting Opioids Used for Chronic Low-Back Pain Treatment among Patients Previously Treated with Short-Acting Opioids
Location: Exhibit Hall (Level 4)

Dimitrije Grbic

Favorite

P-017 - (Poster #17) Opioid Use Disorder Outcomes of Chronic Low Back Pain Patients Transitioned from Oral Schedule II Short-Acting Opioids to Belbuca or Oral Schedule II Long-Acting Opioids: A Retrospective US Commercial Claims Analysis
Location: Exhibit Hall (Level 4)

Dimitrije Grbic

Favorite

Green, Jody

Uprise Health

P-019 - (Poster #19) Opioid Abuse Deterrent Formulations: Evaluation of Nonmedical Use of Other Prescription Opioid Substances and Routes of Administration in Adults Evaluated for Substance Use Treatment with the Addiction Severity Index-Multimedia Version (ASI-MV®)
Location: Exhibit Hall (Level 4)

Jody Green

Favorite

P-020 - (Poster #20) Clinical Outcomes Translated to Healthcare Costs: Comparison of Buprenorphine Pain Medications with Full-agonist Extended-Release Opioids
Location: Exhibit Hall (Level 4)

Jody Green

Favorite

P-021 - (Poster #21) Route of Administration and Other Clinical Outcomes Among Exposures to Buprenorphine Pain Medications and Schedule II Opioids
Location: Exhibit Hall (Level 4)

Jody Green

Favorite

P-022 - (Poster #22) Urine Drug Test Results from Patients with Chronic Pain Receiving Partial Agonist Versus Full Agonist Opioid Therapy
Location: Exhibit Hall (Level 4)

Jody Green

Favorite

Grieco, Joseph

Tris Pharma, Inc.

P-044 - (Poster #44) Results of a Randomized, Placebo-Controlled, Phase 3 Trial of Cebranopadol for the Treatment of Acute Pain After Abdominoplasty
Location: Exhibit Hall (Level 4)

Joseph Grieco

Favorite

Groth, Tim

Groth Pain & Spine

BUS-04 - The Business of Optimizing APPs in Your Pain Practice
Location: Castellana 1 (Level 3)

Tim Groth

Favorite

GML-04 - Documentation for Interventions: Covering the Operating Room and Clinic Settings
Location: Nolita (Level 4)

Tim Groth

Favorite

PNL-04 - (Ask the Panel) Preparing for Tomorrow: The Future Business of Pain
Location: Nolita (Level 4)

Tim Groth

Favorite

Gudin, Jeffrey

Department of Anesthesiology, University of Miami, Miller School of Medicine, Miami, FL, USA

CSS-02 - (CME Lunch Symposium) Chronic Pain Care Today: Real-World Case Discussion to Optimize Benefit-Risk in Opioid Prescribing
Location: Brera Ballroom (Level 3)

Jeffrey Gudin

Favorited

EOL-01 - (Expert Opinion Live) The Value of OTC Medications in the Multimodal Pain Management of Osteoarthritis
Location: Exhibit Hall (Level 4)

Jeffrey Gudin

Favorite

PDM-01 - (Sponsored Breakfast Presentation) There's a Ton to be Excited About with the First FDA-Approved Treatment for Fibromyalgia in Over 15 Years
Location: Brera Ballroom (Level 3)

Jeffrey Gudin

Favorite

PDM-02 - (Sponsored Lunch Presentation) Dual NMR Agonists to overcome the Current Shortfalls in the Management of Severe Acute Pain: Break the Mold in Pain Biology
Location: Brera Ballroom (Level 3)

Jeffrey Gudin

Favorite

PDM-05 - (Sponsored Lunch Presentation) Pain Management, RE-Invented. A New Era for Analgesia.
Location: Brera Ballroom (Level 3)

Jeffrey Gudin

Favorite

PHM-08 - Analgesics of the Future
Location: Mont Royal (Level 4)

Jeffrey Gudin

Favorited

PNL-03 - (Ask the Panel) Un-Blocking Potential: Overcoming Barriers in Pain Management
Location: Mont Royal (Level 4)

Jeffrey Gudin

Favorited

PRC-01 - PAINWeek PreCon - Rounds of Resilience: Optimizing Pain Management Through Interactive Difficult Case Navigation
Location: Nolita (Level 4)

Jeffrey Gudin

Favorite

WRK-01 - (Workshop Showcase) Beyond the Guidelines: Practical and Patient-Centric Non-Opioid and OTC Multimodal Pain Management
Location: Brera Ballroom (Level 3)

Jeffrey Gudin

Favorite

Guesnier, Ashley

Vertex Pharmaceuticals Incorporated

P-003 - (Poster #3) Patient Perspectives of Inadequately Managed Painful Diabetic Peripheral Neuropathy: A Qualitative Analysis
Location: Exhibit Hall (Level 4)

Ashley Guesnier

Favorite

P-004 - (Poster #4) Health Care Professionals’ Perspectives of Inadequately Managed Painful Diabetic Peripheral Neuropathy: A Qualitative Analysis
Location: Exhibit Hall (Level 4)

Ashley Guesnier

Favorite

Guillen, Rocio

Hospital Medica Sur

P-034 - (Poster #34) An Exploration of Painful Neuropathy in the Context of Long Covid: Mechanisms, Manifestations, and Management
Location: Exhibit Hall (Level 4)

Rocio Guillen

Favorite

Gupta, Alankar

Kenvue Brands LLC

P-032 - (Poster #32) The Multimodal Molecule: A Comprehensive, Evidence-based Hierarchical Synthesis of Acetaminophen Mechanisms of Analgesic Action
Location: Exhibit Hall (Level 4)

Alankar Gupta

Favorite

Gupta, Mayank

Kansas Pain Management, Neuroscience Research Center, LLC, & Kansas Surgery Center, LLC

INTV-06 - What's New?! Minimally Invasive Interventions for Low Back Pain
Location: Mont Royal (Level 4)

Mayank Gupta

Favorite